Sayer Kevin R
DexCom, Inc. · Executive Chair
Sayer Kevin R serves as the Executive Chair of DexCom, Inc., a leading company in the healthcare sector known for its innovative diabetes management solutions. His recent disclosures reveal a series of sales totaling approximately $1.9 million from May 26, 2026, to July 7, 2026, all related to DexCom, Inc. (DXCM). Notably, the largest sale occurred on May 26, 2026, amounting to $1,926,648, reflecting his active engagement in managing his holdings.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2M26.8k shares | SellJul 6, 2026 | $72.00 | $76.45 |